The global spinal non-fusion treatment market is expected to grow at a compound annual growth rate of 5.3 percent to $749 million by 2021, according to Wise Guy Reports' research.
Here are four things to know:
1. The cervical total disc replacement market will drive the market's growth, because of available clinical efficacy data and an increase in degenerative spine diseases.
2. The market will see increased activity in the mergers and acquisitions field.
3. DePuy Synthes, Medtronic, Aesculap, Alphatec Spine, Globus Medical, LDR, NuVasive, Paradigm Spine, RTI Surgical and Zimmer-Biomet lead the market.
4. More small- and medium-seized companies are now marketing their artificial disc and non-fusion technologies in the space.